ARCT Arcturus Therapeutics Holdings Inc.
Nasdaq · SEC CIK 1768224 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 91 since 2021-08-05, latest 2026-06-15 17:02
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 41
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-08-20 | 2025-08-15 | ARCT | SASSINE ANDY | CFO, Dir | P - Purchase | $16.56 | +1,238 | 221.8K | +0.6% | +$20.5K |
| 2025-08-19 | 2025-08-15 | ARCT | SASSINE ANDY | CFO, Dir | P - Purchase | $16.56 | -1,238 | 221.8K | -0.6% | -$20.5K | |
| 2024-10-16 | 2024-10-15 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $20.76 | -12.0K | 435.3K | -3% | -$249.1K | |
| D | 2024-06-18 | 2024-06-14 | ARCT | Marantz Jing L. | Dir | M - OptEx | $0.00 | +3,131 | 3,131 | New | $0 |
| D | 2024-06-18 | 2024-06-14 | ARCT | FARRELL PETER C | Dir | M - OptEx | $0.00 | +3,131 | 55.7K | +6% | $0 |
| D | 2024-06-18 | 2024-06-14 | ARCT | BARLOW JAMES F | Dir | M - OptEx | $0.00 | +3,131 | 13.1K | +31% | $0 |
| D | 2024-06-18 | 2024-06-14 | ARCT | Markels John | Dir | M - OptEx | $0.00 | +3,131 | 3,131 | New | $0 |
| D | 2024-06-18 | 2024-06-14 | ARCT | HOLMES EDWARD W | Dir | M - OptEx | $0.00 | +3,131 | 3,131 | New | $0 |
| D | 2024-06-18 | 2024-06-14 | ARCT | Marquet Magda | Dir | M - OptEx | $0.00 | +3,131 | 3,131 | New | $0 |
| 2024-06-14 | 2024-06-12 | ARCT | SASSINE ANDY | CFO, Dir | S - Sale | $32.03 | -50.0K | 220.5K | -18% | -$1.60M | |
| 2024-06-07 | 2024-06-05 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $45.00 | -114 | 447.3K | -0.0% | -$5,130 | |
| 2024-06-04 | 2024-06-03 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $40.01 | -26.0K | 447.4K | -5% | -$1.04M | |
| 2024-03-27 | 2024-03-25 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $35.02 | -17.4K | 473.4K | -4% | -$610.6K | |
| 2024-03-21 | 2024-03-19 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $35.01 | -8,565 | 490.9K | -2% | -$299.9K | |
| 2023-11-03 | 2023-11-01 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $18.72 | -5,000 | 499.4K | -1.0% | -$93.6K | |
| 2023-10-04 | 2023-10-02 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $25.61 | -5,000 | 504.4K | -1.0% | -$128.1K | |
| 2023-09-05 | 2023-09-01 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $31.45 | -5,000 | 509.4K | -1.0% | -$157.2K | |
| 2023-08-17 | 2023-08-15 | ARCT | SASSINE ANDY | CFO, Dir | A - Grant | $17.37 | +1,223 | 270.5K | +0.5% | +$21.2K | |
| 2023-08-03 | 2023-08-01 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $34.91 | -5,000 | 514.4K | -1.0% | -$174.5K | |
| 2023-07-18 | 2023-07-14 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $35.01 | -25.0K | 519.4K | -5% | -$875.2K | |
| D | 2023-07-18 | 2023-07-14 | ARCT | Kummerfeld Keith C | See Remarks | S - Sale+OE | $35.00 | -6,968 | 950 | -88% | -$243.9K |
| DM | 2023-07-18 | 2023-07-14 | ARCT | Kummerfeld Keith C | See Remarks | M - OptEx | $8.96 | +6,968 | 6,887 | New | +$62.4K |
| 2023-07-07 | 2023-07-03 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $28.75 | -5,000 | 544.4K | -0.9% | -$143.8K | |
| 2023-06-05 | 2023-06-01 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $27.16 | -5,000 | 549.4K | -0.9% | -$135.8K | |
| M | 2023-05-12 | 2023-05-10+ | ARCT | Chivukula Pad | CSO, COO | S - Sale | $30.08 | -25.0K | 562.4K | -4% | -$751.9K |
| 2023-05-03 | 2023-05-01 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $25.93 | -5,000 | 579.4K | -0.9% | -$129.7K | |
| DM | 2023-04-19 | 2023-04-18 | ARCT | Kummerfeld Keith C | See Remarks | M - OptEx | $8.96 | +6,968 | 1,981 | New | +$62.4K |
| D | 2023-04-19 | 2023-04-18 | ARCT | Kummerfeld Keith C | See Remarks | S - Sale+OE | $28.18 | -6,968 | 950 | -88% | -$196.4K |
| 2023-04-05 | 2023-04-03 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $25.38 | -5,000 | 584.4K | -0.8% | -$126.9K | |
| 2023-03-08 | 2023-03-06 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $16.07 | -5,000 | 589.4K | -0.8% | -$80.3K | |
| I | 2022-12-19 | 2022-12-15 | ARCT | Marquet Magda | Dir | P - Purchase | $18.00 | +2,222 | 24.9K | +10% | +$40.0K |
| 2022-11-28 | 2022-11-23 | ARCT | Payne Joseph E | Pres, CEO, Dir | P - Purchase | $16.51 | +5,000 | 1.48M | +0.3% | +$82.6K | |
| 2022-08-17 | 2022-08-15 | ARCT | SASSINE ANDY | CFO, Dir | A - Grant | $18.42 | +1,068 | 269.3K | +0.4% | +$19.7K | |
| 2022-01-06 | 2022-01-04 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $40.00 | -8,100 | 594.4K | -1% | -$324.0K | |
| 2021-12-20 | 2021-12-16 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $40.00 | -3,633 | 602.5K | -0.6% | -$145.3K | |
| 2021-12-10 | 2021-12-08 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $40.00 | -6,367 | 606.2K | -1% | -$254.7K | |
| 2021-11-03 | 2021-11-01 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $44.41 | -10.0K | 612.5K | -2% | -$444.1K | |
| 2021-10-04 | 2021-10-01 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $44.36 | -10.0K | 622.5K | -2% | -$443.6K | |
| 2021-09-02 | 2021-09-01 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $55.86 | -10.0K | 632.5K | -2% | -$558.6K | |
| M | 2021-08-12 | 2021-08-10+ | ARCT | Ultragenyx Pharmaceutical Inc. | Dir | S - Sale | $54.54 | -800.0K | 1.48M | -35% | -$43.63M |
| 2021-08-05 | 2021-08-03 | ARCT | Chivukula Pad | CSO, COO | S - Sale | $40.07 | -10.0K | 642.5K | -2% | -$400.7K |
Purchase Sale Sale after option exercise All abbreviations